FBLG — FibroBiologics, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology
$2.11
+$0.39 (+22.67%)
FibroBiologics, Inc. Common Stock (FBLG) is a biotechnology company listed on NASDAQ. It is led by Peter O'Heeron, based in 455 East Medical Center Boulevard, Houston, TX, United States, 77598, with about 13 employees. FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.
Net income was -$5.8M. FBLG currently screens at market cap $24.0M.
Use this FBLG page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the FBLG quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the FBLG SEC filings page. Lician reads the product cache first so this HTML stays unique to FibroBiologics, Inc. Common Stock even when a live quote feed is slow.
About FibroBiologics, Inc. Common Stock
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.
FBLG Key Statistics
Market Cap
$24.02M
Volume
190,939
Previous Close
$1.35
Day Range
$1.33 – $1.49
EPS
-$0.34
Revenue
$0.00
Net Income
-$11.16M
Gross Profit
$0.00
Free Cash Flow
$0.00
Employees
13
FBLG Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 |
| Net Income | -$11.16M | -$16.48M | -$5.12M |
| EPS (Diluted) | -$0.34 | -$0.68 | -$0.18 |
Total Assets
$16.45M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$13.98M
Operating Cash Flow
-$11.90M
Free Cash Flow
$0.00
FibroBiologics, Inc. Common Stock Company Information
- Founder, Chairperson & CEO
- Peter O'Heeron
- Headquarters
- 455 East Medical Center Boulevard, Houston, TX, United States, 77598
- Website
- www.fibrobiologics.com
- Phone
- 281-651-5150
- IPO / Founded
- 2024-01-31
- Sector
- Healthcare
- Industry
- Biotechnology